Skip Navigation

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 Durvalumab vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03258554

Study #:
STUDY00142590

Start Date:
Nov 05, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03258554

View Complete Trial Details & Eligibility at ClinicalTrials.gov